Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial... see more

TSX:WLLW - Post Discussion

Willow Biosciences Inc > Had $30Million less than a year ago, $now $18M
View:
Post by Magnum2 on Dec 14, 2022 4:38pm

Had $30Million less than a year ago, $now $18M

a few months ago...blowing cash like mad, saying they have funded 2023 lab work, then what???

The sand is pouring out hard on this one as revenues are minimal, the sector is in a major transition and the Banking access they needed in the U.S. did not get okayed by Biden.
Another 12 months should wipe away many in the sector, doubt these guys survive given todays' plan/news.

DYODD
Comment by Bullknit101 on May 14, 2023 7:42am
I haven't look at Willow in a while and the promise of Cannabis derived rare cannabinoids seems to have been stymied by a lack of progress of US federal reform. That said, we may at the very of a resurgence trend with the sector as a while. Safe Banking, HOPE, NJ 280e, HHS rescheduling review etc.  Starting build momentum and will likely catch people off guard when plant touching MSOS ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities